Squarepoint’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-17,779
| Closed | -$68K | – | 2604 |
|
|
2020
Q1 | $68K | Buy |
+17,779
| New | +$68K | ﹤0.01% | 1691 |
|
|
2019
Q3 | – | Sell |
-115,461
| Closed | -$712K | – | 2698 |
|
|
2019
Q2 | $712K | Sell |
115,461
-32,015
| -22% | -$197K | 0.01% | 1433 |
|
|
2019
Q1 | $684K | Sell |
147,476
-39,143
| -21% | -$182K | 0.01% | 1303 |
|
|
2018
Q4 | $784K | Buy |
+186,619
| New | +$784K | 0.01% | 1019 |
|
|
2018
Q2 | – | Sell |
-118,973
| Closed | -$888K | – | 2191 |
|
|
2018
Q1 | $888K | Buy |
118,973
+49,661
| +72% | +$371K | 0.01% | 849 |
|
|
2017
Q4 | $412K | Buy |
69,312
+19,768
| +40% | +$118K | 0.01% | 1308 |
|
|
2017
Q3 | $365K | Sell |
49,544
-45,588
| -48% | -$336K | 0.01% | 1078 |
|
|
2017
Q2 | $646K | Buy |
95,132
+40,833
| +75% | +$277K | 0.01% | 856 |
|
|
2017
Q1 | $513K | Buy |
54,299
+13,740
| +34% | +$130K | 0.01% | 839 |
|
|
2016
Q4 | $350K | Buy |
40,559
+29,460
| +265% | +$254K | 0.01% | 1057 |
|
|
2016
Q3 | $70K | Buy |
+11,099
| New | +$70K | ﹤0.01% | 968 |
|
|
2016
Q1 | – | Sell |
-41,300
| Closed | -$253K | – | 1560 |
|
|
2015
Q4 | $253K | Buy |
+41,300
| New | +$253K | 0.03% | 878 |
|
|
2015
Q2 | – | Sell |
-26,972
| Closed | -$161K | – | 662 |
|
|
2015
Q1 | $161K | Buy |
+26,972
| New | +$161K | 0.06% | 386 |
|